The update from the 12th of April was an indicator for a...

The update from the 12th of April was an indicator for a watershed moment this year for investors when CNS candidate is shared.

That should coincide with first toxicity numbers for the first program.

My timeline is adjusted from mid this year to end of Q3 for that to look forward to.


Forward looking estimates, particularly as part of a presentation during a CR are rarely met.
My entry into the stock was therefore timed to see all the hype disappear and await a bottoming of the chart.
That bottom was 13.5 cents.

We now sit on a higher low at 15 cents, which sits well with the charts.


CNS candidate update Sept/ Oct should be a watershed moment for investors for
which I keep positioning myself.

Scientific milestones have been met very impressively, which is what I look for,
particularly the update from the 12th of April.


all IMO